Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.93% | 36.82 | 0.9% | $1164.76m | |
| JNJ | Johnson & Johnson | 1.75% | 164.56 | 0.7% | $1136.72m | |
| LLY | Eli Lilly & Co. | 1.89% | 206.17 | 1.1% | $885.93m | |
| ABBV | AbbVie, Inc. | 0.07% | 111.34 | 1.9% | $726.45m | |
| BMY | Bristol-Myers Squibb Co. | 1.15% | 64.92 | 1.0% | $672.97m | |
| MRK | Merck & Co., Inc. | 0.01% | 81.19 | 0.7% | $665.83m | |
| AZN | AstraZeneca Plc | 1.50% | 53.34 | 1.2% | $665.10m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 4.34% | 66.54 | 0.0% | $227.70m | |
| GRTS | Gritstone Oncology, Inc. | 9.20% | 27.90 | 0.0% | $209.79m | |
| VTRS | Viatris, Inc. | 0.82% | 17.45 | 0.0% | $194.31m | |
| RPRX | Royalty Pharma Plc | 1.69% | 51.27 | 0.2% | $174.33m | |
| NVS | Novartis AG | 0.25% | 97.12 | 0.2% | $166.27m | |
| GSK | GlaxoSmithKline Plc | 1.58% | 38.38 | 0.2% | $149.01m | |
| SNY | Sanofi | 0.57% | 49.93 | 0.2% | $129.20m | |
| RGEN | Repligen Corp. | 0.58% | 218.17 | 6.9% | $82.15m |
Company Profile
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.